FMT increased gut levels of SCFAs in PD mice, upregulated SCFA receptors FFAR2 and FFAR3 in the CNS, enhanced dopamine and serotonin levels in the striatum, promoted the survival of dopaminergic neurons in the substantia nigra, and reduced glial cell activation. The gene discussed is FFAR2; the disease is Parkinson disease.